Top Banner
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Timby/Smith: Introductory Medical-Surgical Nursing, 10/e Chapter 34: Caring for Clients with Immune-Mediated Disorders
25
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Timby/Smith: Introductory Medical-Surgical Nursing, 10/e

Timby/Smith: Introductory Medical-Surgical Nursing, 10/e

Chapter 34: Caring for Clients with Immune-Mediated Disorders

Page 2: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Allergic Disorders Allergic Disorders

• Hyperimmune response to weak antigens that are typically harmless

• Organs, structures primarily involved:

– Skin

– Respiratory passageways

– GI tract

– Blood, vascular system

Page 3: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Allergic Disorders Allergic Disorders

• Pathophysiology and Etiology

– Tendency can be inherited

– Sensitization

– Hypersensitivity response

• Immediate; Delayed

Page 4: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

Is the following statement true or false?

There is more than one type of hypersensitivity response.

Page 5: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

True.

There is more than one type of hypersensitivity response. The response can be immediate or delayed.

Page 6: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Allergic Disorders Allergic Disorders

Page 7: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Hypersensitivity ResponsesHypersensitivity Responses• Immediate Hypersensitivity Responses

– Type I: Atopic; Anaphylactic

• Most severe; IgE mediated

– Type II: Cytotoxic

• IgM or IgG mediated

– Type III: Immune complex

• IgG mediated

• Delayed Hypersensitivity Response: Type IV

• Allergic response suppression

Page 8: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Allergic Disorders Allergic Disorders • Assessment Findings: Signs and Symptoms

– Cause-and-effect relationship

• Symptom correlation

• Consistent exposure reaction to allergen

• Assessment Findings: Diagnostic Findings

– RAST

– Scratch (or prick) test

– Patch test

– Intradermal injection test

Page 9: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestionIs the following statement true or false?

Allergic reaction symptoms are unconnected to the exposure route.

Page 10: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswerFalse.

Allergic reaction symptoms typically have a cause-and-effect correlation to the route of exposure to the allergen.

Page 11: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Allergic Disorders Allergic Disorders • Inhalant Allergy Potential Complications

– Nasal polyps; Sinus infections; Asthma

– Secondary pulmonary infections

• Most Severe Complications of any Allergy Type

– Anaphylactic shock; Angioneurotic edema

• Medical Management

– Allergen avoidance

– Symptomatic; Drug therapy; Emergency kit

– Desensitization

Page 12: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing ManagementNursing Management

• Diagnostic Skin Testing

• Observe for allergic reaction

• Remove the offending substance

• Notify the physician

• Anaphylactic reaction

• Removal of ring from a swelling finger

• Temporary discontinuation of some medications

Page 13: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing ManagementNursing Management

• Desensitization

– Administer serial doses; Monitor for 30 minutes

– Sublingual-swallow immunotherapy

• Allergic rhinitis

– Client teaching

• Prescribed medications: Self-administration; Side effects

• Reduce exposure at home and work

Page 14: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

Is the following statement true or false?

A newer type of desensitization therapy uses sublingual-swallow immunotherapy for several types of allergic reactions.

Page 15: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

False.

A newer type of desensitization therapy uses sublingual-swallow immunotherapy. It is used as a desensitization treatment for allergic rhinitis.

Page 16: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing ProcessNursing Process• Assessment

– Thorough history: Diet and family

– Record

• Allergic symptoms

• Factors that appear to increase or decrease symptoms

– Prescription or nonprescription drugs taken

– Skin rashes or eruptions

– Observation and monitoring each time a new drug is given

Page 17: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing ProcessNursing Process• Diagnosis, Planning, and Interventions

– Altered comfort: Itching

– Impaired home maintenance

– PC: Anaphylaxis and angioedema

• Evaluation of Expected Outcomes

– Relief of itching; No evidence of rash

– Stable vital signs

– Effortless breathing

– Necessary changes made at home

Page 18: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Autoimmune Disorders Autoimmune Disorders • Pathophysiology and Etiology

– Unrelenting, progressive tissue damage

– Killer T cells; Autoantibodies attack “self”

– Triggering event

• Assessment Findings: Signs and Symptoms

– Acute inflammatory response

– Low-grade fever; Malaise; Weight loss

– Alternating exacerbations, remissions

• Assessment Findings: Diagnostic Findings

– Elevated circulating antibodies

Page 19: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Autoimmune Disorders Autoimmune Disorders • Medical Management

– Rarely cured

– Goal: Remission; Slowing destruction

– Drug therapy

• Anti-inflammatory agents; Immunosuppressive agents; Antineoplastic drugs

– Controlling side effects of drugs

– Continued medication to avoid recursive exacerbation

Page 20: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Process: Autoimmune DisorderNursing Process: Autoimmune Disorder

• Assessment

– Family history

– Vital signs

– Signs of localized inflammation and compromised body functions

– Client’s level of energy

– Laboratory test findings

– Client teaching

Page 21: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Nursing Process: Autoimmune Disorder Nursing Process: Autoimmune Disorder • Diagnosis, Planning, and Interventions

– Activity intolerance

– Risk for infection

– Disturbed personal identity

• Evaluation of Expected Outcomes

– Participation in self-care, ADLs without overwhelming fatigue

– No evidence of iatrogenic infection

– Realistic self-perception

Page 22: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Chronic Fatigue Syndrome Chronic Fatigue Syndrome • Profound fatigue without identifiable cause,

unrelenting for 6+ months

• Pathophysiology and Etiology

– No known cause: Possible combination of immune defects, viral assault

– Low serum cortisol levels; Impaired activation of HPA axis

• Assessment Findings: Signs and Symptoms

– Ongoing fatigue plus at least four additional signs, symptoms

– Neurologic symptoms (several)

Page 23: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Chronic Fatigue Syndrome Chronic Fatigue Syndrome • Assessment Findings: Diagnostic Findings

– Medical history, physical examination

• Unremarkable findings

– Blood tests

– Exhaustive medical workup

– Tilt-table test

Page 24: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Chronic Fatigue Syndrome Chronic Fatigue Syndrome • Medical Management

– Drug treatment: Symptomatic; Investigational

– Balanced activity, rest

– Hypotension: Increased salt, water intake

– Several adjunct and alternative therapies

• Nursing Management

– Client education: Disease process; Accommodating limitations

Page 25: Chapter034

Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

End of Presentation